Get started
Award

22932

Funded outputs count: 41
Funder award ID: 22932
OpenAlex ID: G7212898136
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
2023 · Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, et al. · BMJ · 37
PDF
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays
2023 · Niklas Krumm, Nithisha S. Khasnavis, et al. · JCO Precision Oncology · 6
PDF
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression
2023 · Stefan J. Hutten, Roebi de Bruijn, et al. · Cancer Cell · 34
PDF
A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer
2022 · Marine Inglebert, Martina Dettwiler, et al. · Scientific Reports · 41
PDF
Learning to distinguish progressive and non-progressive ductal carcinoma in situ
2022 · Anna K. Casasent, Mathilde M. Almekinders, et al. · Nature reviews. Cancer · 50
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
2022 · Erika Durinikova, Nicole M. Reilly, et al. · Clinical Cancer Research · 60
PDF
Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
2020 · Vasiliki Papadaki, Ken Asada, et al. · Cancers · 31
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
2020 · R.E. Miller, A. Leary, et al. · Annals of Oncology · 483
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
2020 · Matthew H. Bailey, William U. Meyerson, et al. · Nature Communications · 52
PDF
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
2020 · Dominik Glodzik, Ana Bosch, et al. · Nature Communications · 127
PDF
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
2020 · Neha Chopra, Holly Tovey, et al. · Nature Communications · 259
PDF
Transcription-coupled repair and mismatch repair contribute towards preserving genome integrity at mononucleotide repeat tracts
2020 · Ilias Georgakopoulos-Soares, Gene Koh, et al. · Nature Communications · 28
PDF
Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions
2020 · Oliver Thompson, Ferdinand von Meyenn, et al. · Nature Communications · 140
PDF
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
2020 · Andrea Degasperi, Tauanne Dias Amarante, et al. · Nature Cancer · 299
Mutational signatures: experimental design and analytical framework
2020 · Gene Koh, Xueqing Zou, et al. · Genome biology · 39
PDF
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
2020 · Wei Jiao, Gurnit Atwal, et al. · Nature Communications · 217
PDF
Pan-cancer analysis of whole genomes
2020 · Lauri A. Aaltonen, Federico Abascal, et al. · Nature · 3,055
PDF
Holistic cancer genome profiling for every patient
2020 · Serena Nik-Zainal, Yasin Memari, et al. · Swiss Medical Weekly · 6
Cellular survival over genomic perfection
2019 · Serena Nik-Zainal, Benjamin A. Hall · Science · 31
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
2019 · Helen R. Davies, Kirsty Hodgson, et al. · Nature Communications · 35
PDF
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease
2019 · Sophie Momen, Hiva Fassihi, et al. · Molecular Case Studies · 48
PDF
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
2019 · Lindsay Angus, Marcel Smid, et al. · Nature Genetics · 309
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
2019 · Johan Staaf, Dominik Glodzik, et al. · Nature Medicine · 305
Ductal carcinoma in situ: to treat or not to treat, that is the question
2019 · on behalf of the PRECISION team, Maartje van Seijen, et al. · British Journal of Cancer · 320
PDF
A practical guide for mutational signature analysis in hematological malignancies
2019 · Francesco Maura, Andrea Degasperi, et al. · Nature Communications · 183
PDF
Year
Topic